Clinical variables impacting on the estimation of utilities in chronic obstructive pulmonary disease

International Journal of COPD

Volumn 10, Issue , 2015, Pages 367-377

  Miravitlles, Marc ^a,b   Huerta, Alicia ^c   Valle, Manuel ^d   García Sidro, Patricia ^e   Forné, Carles ^f   Crespo, Carlos ^f,g   López Campos, José Luis ^b,h  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b GLAXOSMITHKLINE   (Spain)

^c Market Access Department GlaxosmithKline   (Spain)

^d HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

^e La Plana Hospital   (Spain)

^f Oblikue Consulting   (Spain)

^g UNIVERSITY OF BARCELONA   (Spain)

^h HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

Author keywords

COPD; Health utility; Health related quality of life; Multivariate linear regression

Indexed keywords

ADULT; ARTICLE; CHARLSON COMORBIDITY INDEX; CHRONIC OBSTRUCTIVE LUNG DISEASE; CROSS-SECTIONAL STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH CARE UTILIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MULTICENTER STUDY; QUALITY ADJUSTED LIFE YEAR; QUESTIONNAIRE; SCORING SYSTEM; SEX DIFFERENCE; SMOKING; AGED; CLINICAL TRIAL; DISEASE COURSE; HEALTH CARE PLANNING; HEALTH STATUS; LUNG; MIDDLE AGED; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PSYCHOLOGY; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; SPAIN; STATISTICAL MODEL; TIME; TREATMENT OUTCOME; UTILIZATION; VITAL CAPACITY;

AGED; CROSS-SECTIONAL STUDIES; DISEASE PROGRESSION; DYSPNEA; FEMALE; FORCED EXPIRATORY VOLUME; HEALTH RESOURCES; HEALTH STATUS; HUMANS; LINEAR MODELS; LUNG; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; SEX FACTORS; SPAIN; SURVEYS AND QUESTIONNAIRES; TIME FACTORS; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 84923188321     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: 10.2147/COPD.S76397     Document Type: Article

References (42)

1. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet. 2012;379(9823):1341–1351.
2. López-Campos JL, Ruiz-Ramos M, Soriano JB. Mortality trends in chronic obstructive pulmonary disease in Europe, 1994–2010: a joinpoint regression analysis. Lancet Respir Med. 2014;2(1):54–62.
3. Miravitlles M, Soriano JB, García-Río F, et al. Prevalence of COPD in Spain: impact of undiagnosed COPD on quality of life and daily activities. Thorax. 2009;64(10):863–868.
4. Ferrer M, Alonso J, Morera J, et al. Chronic obstructive pulmonary disease stage and health-related quality of life. The Quality of Life of Chronic Obstructive Pulmonary Disease Study Group. Ann Intern Med. 1997; 127(12):1072–1079.
5. Torrance G W. Measurement of health state utilities for economic appraisal. J Health Econ. 1986;5(1):1–30.
6. Ara R, Wailoo AJ. NICE DSU Technical Support Document 12: the use of health state utility values in decision models. Sheffield, UK: Decision Support Unit; 2011. Available from: http://www.nicedsu.org.uk/TSD12%20Utilities%20in%20modelling%20FINAL.pdf. Accessed October 22, 2014.
7. Husereau D, Drummond M, Petrou S, et al; ISPOR Health Economic Evaluation Publication Guidelines-CHEERS Good Reporting Practices Task Force. Consolidated Health Economic Evaluation Reporting Standards (CHEERS) – explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force. Value Health. 2013;16(2): 231–250.
8. EuroQol Group. EuroQol – a new facility for measurement of health-related quality of life. Health Policy. 1990;16(3):199–208.
9. Haute Autorité de Santé. Choices in Methods for Economic Evaluation. France: Department of Economics and Public Health Assessment; 2012 Available from: http://www.has-sante.fr/portail/upload/docs/application/pdf/2012-10/choices_in_methods_for_economic_ evaluation.pdf. Accessed October 22, 2014.
10. Ståhl E, Lindberg A, Jansson SA, et al. Health-related quality of life is related to COPD disease severity. Health Qual Life Outcomes. 2005; 3:56.
11. Pickard AS, Wilke C, Jung E, Patel S, Stavem K, Lee TA. Use of a preference-based measure of health (EQ-5D) in COPD and asthma. Respir Med. 2008;102(4):519–536.
12. Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages? Chest. 2006;130(4):1117–1128.
13. Ringbaek T, Brøndum E, Martinez G, Lange P. EuroQoL in assessment of the effect of pulmonary rehabilitation COPD patients. Respir Med. 2008;102(11):1563–1567.
14. Miravitlles M, Izquierdo I, Herrejón A, Torres JV, Baró E, Borja J; ESFERA investigators. COPD severity score as a predictor of failure in exacerbations of COPD. The ESFERA study. Respir Med. 2011;105(5): 740–747.
15. Miravitlles M, Naberan K, Cantoni J, Azpeitia A. Socioeconomic status and health-related quality of life of patients with chronic obstructive pulmonary disease. Respiration. 2011;82(5):402–408.
16. Naberan K, Azpeitia A, Cantoni J, Miravitlles M. Impairment of quality of life in women with chronic obstructive pulmonary disease. Respir Med. 2012;106(3):367–373.
17. Miravitlles M, Soriano JB, Ancochea J, et al. Characterisation of the overlap COPD-asthma phenotype. Focus on physical activity and health status. Respir Med. 2013;107(7):1053–1060.
18. Miravitlles M, Huerta A, Fernández-Villar JA, et al. Generic utilities in chronic obstructive pulmonary disease patients stratified according to different staging systems. Health Qual Life Outcomes. 2014; 12(1):120.
19. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
20. Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654.
21. Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA. Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax. 1999;54(7):581–586.
22. Badia X, Roset M, Herdman M, Kind P. A comparison of United Kingdom and Spanish general population time trade-off values for EQ-5D health states. Med Decis Making. 2001;21(1):7–16.
23. Brazier JE, Yang Y, Tsuchiya A, Rowen DL. A review of studies mapping (or cross walking) non-preference based measures of health to generic preference-based measures. Eur J Health Econ. 2010;11(2): 215–225.
24. R Core Team. R: A Language and Environment for Statistical Computing. Vienna: R Foundation for Statistical Computing; 2013. Available from: http://www.R-project.org/. Accessed October 22, 2014.
25. Spanish Statistical Office. Encuesta Nacional de Salud de España 2011–2012 [Spanish National Health Survey 2011–2012]. Latest published data, 2013. Available from: http://www.ine.es/jaxi/menu.do;jsessionid=F1AC5C5327BC8A876380E258216895FA.jaxi01?type=pcaxis&path=/t15/p419&fle=inebase&L=1. Accessed October 22, 2014.
26. Tsiligianni I, Kocks J, Tzanakis N, Siafakas N, van der Molen T. Factors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlations. Prim Care Respir J. 2011;20(3):257–268.
27. Carrasco Garrido P, de Miguel Díez J, Rejas Gutiérrez J, et al. Negative impact of chronic obstructive pulmonary disease on the health-related quality of life of patients. Results of the EPIDEPOC study. Health Qual Life Outcomes. 2006;4:31.
28. de Torres JP, Casanova C, Hernández C, et al. Gender associated differences in determinants of quality of life in patients with COPD: a case series study. Health Qual Life Outcomes. 2006;4:72.
29. Raherison C, Tillie-Leblond I, Prudhomme A, et al. Clinical characteristics and quality of life in women with COPD: an observational study. BMC Womens Health. 2014;14(1):31.
30. Miravitlles M, Molina J, Naberan K, Cots JM, Ros F, Llor C; EVOCA study. Factors determining the quality of life of patients with COPD in primary care. Ther Adv Respir Dis. 2007;1(2):85–92.
31. Villar Balboa I, Carrillo Muñoz R, Regí Bosque M, Marzo Castillejo M, Arcusa Villacampa N, Segundo Yagüe M. [Factors associated with the quality of life in patients with chronic obstructive pulmonary disease]. Aten Primaria. 2014;46(4):179–187. Spanish.
32. Garcia-Aymerich J, Hernandez C, Alonso A, et al. Effects of an integrated care intervention on risk factors of COPD readmission. Respir Med. 2007;101(7):1462–1469.
33. Esteban C, Quintana JM, Aburto M, et al. Impact of changes in physical activity on health-related quality of life among patients with COPD. Eur Respir J. 2010;36(2):292–300.
34. Miravitlles M, Cantoni J, Naberan K. Factors associated with low level of physical activity in patients with chronic obstructive pulmonary disease. Lung. 2014;192(2):259–265.
35. Seemungal TA, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157(5 Pt 1):1418–1422.
36. Miravitlles M, Calle M, Alvarez-Gutierrez F, Gobartt E, López F, Martín A. Exacerbations, hospital admissions and impaired health status in chronic obstructive pulmonary disease. Qual Life Res. 2006;15(3): 471–480.
37. Miravitlles M, Ferrer M, Pont A, et al; IMPAC Study Group. Effect of exacerbations on quality of life in patients with chronic obstructive pulmonary disease: a 2 year follow up study. Thorax. 2004; 59(5):387–395.
38. García-Polo C, Alcázar-Navarrete B, Ruiz-Iturriaga LA, et al; InEPOC Group. Factors associated with high healthcare resource utilisation among COPD patients. Respir Med. 2012;106(12):1734–1742.
39. Bentsen SB, Miaskowski C, Rustøen T. Demographic and clinical characteristics associated with quality of life in patients with chronic obstructive pulmonary disease. Qual Life Res. 2014;23(3):991–998.
40. Sundh J, Ställberg B, Lisspers K, Montgomery SM, Janson C. Co-morbidity, body mass index and quality of life in COPD using the Clinical COPD Questionnaire. COPD. 2011;8(3):173–181.
41. Jones P, Miravitlles M, van der Molen T, Kulich K. Beyond FEV1 in COPD: a review of patient-reported outcomes and their measurement. Int J Chron Obstruct Pulmon Dis. 2012;7:697–709.
42. Pickard AS, Yang Y, Lee TA. Comparison of health-related quality of life measures in chronic obstructive pulmonary disease. Health Qual Life Outcomes. 2011;9:26.